CG Oncology
Company Overview
Overall Headcount Trend
Overall Headcount Trend
Company growth over the last 12 months
Hiring Activity
Open Marketing Jobs Over Time
Historical trend of active job postings
Salaries
Job Posting Salary Data
From 1 marketing roles posted in the last 12 months
Community Salary Data
Help build salary transparency at CG Oncology. Share your compensation anonymously.
Reviews
News
Jobs
About CG Oncology
CG Oncology, Inc. (Nasdaq: CGON), is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative oncolytic immunotherapies to live with dignity and have an enhanced quality of life.Our lead candidate, cretostimogene grenadenorepvec, is an intravesically delivered oncolytic immunotherapy agent in a Phase 3 trial for the treatment of BCG-unresponsive non-muscle invasive bladder cancer. Cretostimogene grenadenorepvec is also in a Phase 2 study in combination with KEYTRUDA® (pembrolizumab) in the same indication. Other types of bladder cancer are being evaluated with cretostimogene grenadenorepvec in combination with OPDIVO® (nivolumab).
Company Information
- Company Type
- In-House Team
- Company Size
- Founded
- 2010
- Headquarters
- Irvine
Why Work at CG Oncology?
Discover what makes CG Oncology a great place to build your marketing career. View salary data, benefits, and employee insights on the other tabs.
